Clinical findings show association between nadunolimab and lower incidence and later onset of CIPN Preclinical data show ...

An Oxford researcher is set to run the London Marathon to raise funds for pancreatic cancer research in the UK.

Clinical findings show association between nadunolimab and lower incidence and later onset of CIPNPreclinical data show prevention of ...

Instead, they increased Marie-Noële’s pain meds, removed her hydration IV and let her die of dehydration over the next six ...

Celebrities will often try anything to look good and stay in shape. And as well as a whole host of beauty treatments and tweakments many turn to their diet in the search of body perfection.

A woman said she was inspired to run her first marathon by her dad's rare cancer diagnosis. Zoë Driver, who lives in Wylye ...

Symptoms, and Treatment Liver cancer is one of the most challenging forms of cancer, often developing quietly before showing any clear signs. It begins when abnormal cells form in the liver, a vital ...

Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between normal and pancreatic cancer cells in mice, and that the normal cells may ...

For 45-year-old Marcus Wendling, who toughed out a half Ironman challenge, a diagnosis of stage 3 rectal cancer came out as a ...

New research suggests that cancer patients referred for outpatient palliative care may not be receiving adequate treatment for pain.

Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between ...

Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) developed by Keymed, received Investigational New Drug (IND) ...